Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: An Asian cooperative study between Japan and Korea

Journal of Vascular and Interventional Radiology

Volumn 24, Issue 4, 2013, Pages 490-500

  Ikeda, Masafumi ^a   Arai, Yasuaki ^b   Park, Sang Joon ^c   Takeuchi, Yoshito ^b   Anai, Hiroshi ^d   Kim, Jae Kyu ^e   Inaba, Yoshitaka ^f   Aramaki, Takeshi ^g   Kwon, Se Hwan ^h   Yamamoto, Seiichiro ⁱ   Okusaka, Takuji ^b  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c Sun General Hospital   (South Korea)

^d NARA MEDICAL UNIVERSITY   (Japan)

^e Chonnam National University Medical School   (South Korea)

^f AICHI CANCER CENTER HOSPITAL   (Japan)

^g SHIZUOKA CANCER CENTER   (Japan)

^h Kyung Hee University College of Medicine   (South Korea)

ⁱ NATIONAL CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; DOXORUBICIN; EPIRUBICIN; IODINATED POPPYSEED OIL;

ABDOMINAL PAIN; ADULT; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; BLOOD TOXICITY; CANCER GROWTH; CANCER SURVIVAL; CARDIOTOXICITY; CHEMOEMBOLIZATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG FATALITY; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; HUMAN; INOPERABLE CANCER; JAPAN; KOREA; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALAISE; MALE; NAUSEA; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

AGED; AGED, 80 AND OVER; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ETHIODIZED OIL; FEMALE; GELATIN SPONGE, ABSORBABLE; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84875243085     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.01.003     Document Type: Article

References (26)

1. T. Matsuda, T. Marugame, K.I. Kamo, K. Katanoda, W. Ajiki, and T. Sobue The Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project Jpn J Clinl Oncol 41 2011 139 147
2. I. Ikai, S. Arii, and M. Okazaki Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. The Liver Cancer Study Group of Japan. Hepatol Res 37 2007 676 691
3. M. Kudo, N. Izumi, and N. Kokudo Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version Dig Dis 29 2011 339 364
4. J. Bruix, and M. Sherman Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
5. S.W. Shin The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma Korean J Radiol 10 2009 425 434
6. D.Y. Lin, Y.F. Liaw, T.Y. Lee, and C.M. Lai Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma - a randomized controlled trial Gastroenterology 94 1988 453 456
7. G. Pelletier, A. Roche, and O. Ink A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma J Hepatol 11 1990 181 184
8. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma N Engl J Med 332 1995 1294 1296
9. G. Pelletier, M. Ducreux, and F. Gay Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial J Hepatol 29 1998 129 134
10. J. Bruix, J.M. Llovet, and A. Castells Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized controlled trial in a single institution Hepatology 27 1998 1578 1583
11. C.M. Lo, H. Ngan, and W.K. Tso Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171
12. J.M. Llovet, M.I. Real, and X. Montana Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739
13. M. Doffoël, F. Bonnetain, and O. Bouché Multicentre randomised phase III trial comparing tamoxifen alone or with transarterial lipiodol chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402) Eur J Cancer 44 2008 528 538
14. C. Cammà, F. Schepis, and A. Orlando Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 2002 47 54
15. J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442
16. S. Kawai, M. Tani, and J. Okamura Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study) The Cooperative Study Group for Liver Cancer Treatment of Japan. Semin Oncol 24 2 suppl 6 1997 S6 38-S6-45
17. R. Yamada, M. Sato, M. Kawabata, H. Nakatsuka, K. Nakamura, and S. Takashima Hepatic artery embolization in 120 patients with unresectable hepatoma Radiology 148 1983 397 401
18. H. Nakamura, T. Hashimoto, H. Oi, and S. Sawada Transcatheter oily chemoembolization of hepatocellular carcinoma Radiology 170 1989 783 786
19. H. Uchida, H. Ohishi, and N. Matsuo Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma Cardiovasc Intervent Radiol 13 1990 140 145
20. R. Lencioni, and J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 2010 52 60
21. S. Miyayama, O. Matsui, and M. Yamashiro Ultraselective transcatheter arterial chemoembolization with a 2-F tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil J Vasc Interv Radiol 18 2007 365 376
22. S.K. Ji, Y.K. Cho, and Y.S. Ahn Multivariate analysis of the predictors of survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: focusing on superselective chemoembolization Korean J Radiol 9 2008 534 540
23. R. Lencioni, K. Malagari, and T. Vogl A randomized phase II trial of a drug eluting bead in the treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization [abstract 4598]. J Clin Oncol 26 suppl 2008
24. H. van Malenstein, G. Maleux, and V. Vandecaveye A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma Onkologie 34 2011 368 376
25. M. Kudo, K. Imanaka, and N. Chida Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma Eur J Cancer 47 2011 2117 2127
26. R. Lencioni, J.M. Llovet, and G. Han Sorafenib or placebo in combination with transarterial chemoembolization with doxorubicin-eluting beads for intermediate-stage hepatocellular carcinoma: phase II, randomized, double-blind SPACE trial [abstract LBA154] J Clin Oncol 30 suppl 4 2012